Vol 12: Use of service data to inform pediatric HIV-free survival following prevention of mother-to-child transmission programs in rural Malawi.Report as inadecuate



 Vol 12: Use of service data to inform pediatric HIV-free survival following prevention of mother-to-child transmission programs in rural Malawi.


Vol 12: Use of service data to inform pediatric HIV-free survival following prevention of mother-to-child transmission programs in rural Malawi. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 12: Use of service data to inform pediatric HIV-free survival following prevention of mother-to-child transmission programs in rural Malawi.
This article is from BMC Public Health, volume 12.AbstractBackground: Recent years have seen rapid and significant progress in science and implementation of programs to prevent mother-to-child transmission of HIV. Programs that support PMTCT routinely monitor service provision but very few have measured their effectiveness. The objective of the study was to use service data to inform HIV-free survival among HIV exposed children that received antiretroviral drugs to prevent mother-to-child transmission PMTCT of HIV. The study was conducted in two rural districts in Malawi with support from FHI 360. Methods: A descriptive observational study of PMTCT outcomes was conducted between June 2005 and June 2009. The dataset included patient-level data of all pregnant women 1 that tested HIV-positive, 2 that were dispensed with antiretroviral prophylaxis, and 3 whose addresses were available for home visits. The data were matched to each woman’s corresponding antenatal clinic data from home visit registers. Results: Out of 438 children whose home addresses were available, 33 8% were lost to follow-up, 35 8% were alive but not tested for HIV by the time home visit was conducted, and 52 12% were confirmed deceased. A total of 318 children were alive at the time of the home visit and had an HIV antibody test done at median age 15 months. The resulting estimated 24-month probability of HIV-free survival over all children was 78%. Among children who did not receive nevirapine, the estimated 24-month probability of HIV-free survival was 61%, and among those who did receive NVP syrup the estimate was 82%. Conclusions: When mothers and newborns received nevirapine, the estimated 24-month probability of HIV-free survival among children was high at 82% CI: 54% to 99%. However this conclusion should be interpreted cautiously 1 due to the wide confidence interval; and 2 because the confidence interval range includes 55%, which is the natural HIV-free survival rate in the absence of a PMTCT intervention. This analysis highlighted the need of quality data and well-structured home visits to assess PMTCT effectiveness.



Author: Mandala, Justin; Moyo, Tiwonge; Torpey, Kwasi; Weaver, Mark; Suzuki, Chiho; Dirks, Rebecca; Hayashi, Chika

Source: https://archive.org/







Related documents